Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | 19.35% | $ 46.06M | $ 238.06M |
3/31/2025 | 16.01% | $ 37.25M | $ 232.71M |
12/31/2024 | 13.44% | $ 30.97M | $ 230.47M |
9/30/2024 | 13.3% | $ 32.4M | $ 243.57M |
6/30/2024 | 8.63% | $ 18.91M | $ 219.14M |
3/31/2024 | 11.46% | $ 25.98M | $ 226.63M |
12/31/2023 | 13.85% | $ 32.64M | $ 235.64M |
9/30/2023 | 12.16% | $ 27.86M | $ 229.13M |
6/30/2023 | 9.42% | $ 21.67M | $ 230.12M |
3/31/2023 | 12.27% | $ 28.83M | $ 235.07M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for PUMA BIOTECHNOLOGY INC is calculated as follows: Op. Inc. [ $ -27.97M ] / Revenues [ $ 235.47M ]
(=) Operating % [ -11.88% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |